Literature DB >> 21243012

NF-κB in immunobiology.

Matthew S Hayden1, Sankar Ghosh.   

Abstract

NF-κB was first discovered and characterized 25 years ago as a key regulator of inducible gene expression in the immune system. Thus, it is not surprising that the clearest biological role of NF-κB is in the development and function of the immune system. Both innate and adaptive immune responses as well as the development and maintenance of the cells and tissues that comprise the immune system are, at multiple steps, under the control of the NF-κB family of transcription factors. Although this is a well-studied area of NF-κB research, new and significant findings continue to accumulate. This review will focus on these areas of recent progress while also providing a broad overview of the roles of NF-κB in mammalian immunobiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21243012      PMCID: PMC3193440          DOI: 10.1038/cr.2011.13

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  198 in total

1.  A Toll-like receptor recognizes bacterial DNA.

Authors:  H Hemmi; O Takeuchi; T Kawai; T Kaisho; S Sato; H Sanjo; M Matsumoto; K Hoshino; H Wagner; K Takeda; S Akira
Journal:  Nature       Date:  2000-12-07       Impact factor: 49.962

2.  Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria.

Authors:  T Ayabe; D P Satchell; C L Wilson; W C Parks; M E Selsted; A J Ouellette
Journal:  Nat Immunol       Date:  2000-08       Impact factor: 25.606

3.  The anti-apoptotic activities of Rel and RelA required during B-cell maturation involve the regulation of Bcl-2 expression.

Authors:  M Grossmann; L A O'Reilly; R Gugasyan; A Strasser; J M Adams; S Gerondakis
Journal:  EMBO J       Date:  2000-12-01       Impact factor: 11.598

4.  Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite.

Authors:  M A Campos; I C Almeida; O Takeuchi; S Akira; E P Valente; D O Procópio; L R Travassos; J A Smith; D T Golenbock; R T Gazzinelli
Journal:  J Immunol       Date:  2001-07-01       Impact factor: 5.422

5.  Targeted mutation of TNF receptor I rescues the RelA-deficient mouse and reveals a critical role for NF-kappa B in leukocyte recruitment.

Authors:  E Alcamo; J P Mizgerd; B H Horwitz; R Bronson; A A Beg; M Scott; C M Doerschuk; R O Hynes; D Baltimore
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

6.  Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines.

Authors:  D S Weih; Z B Yilmaz; F Weih
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

7.  NF-kappa B activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development.

Authors:  R E Voll; E Jimi; R J Phillips; D F Barber; M Rincon; A C Hayday; R A Flavell; S Ghosh
Journal:  Immunity       Date:  2000-11       Impact factor: 31.745

8.  NF-kappa B/Rel participation in the lymphokine-dependent proliferation of T lymphoid cells.

Authors:  A Mora; J Youn; A Keegan; M Boothby
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

9.  IkappaB kinase alpha is essential for mature B cell development and function.

Authors:  T Kaisho; K Takeda; T Tsujimura; T Kawai; F Nomura; N Terada; S Akira
Journal:  J Exp Med       Date:  2001-02-19       Impact factor: 14.307

10.  BAFF mediates survival of peripheral immature B lymphocytes.

Authors:  M Batten; J Groom; T G Cachero; F Qian; P Schneider; J Tschopp; J L Browning; F Mackay
Journal:  J Exp Med       Date:  2000-11-20       Impact factor: 14.307

View more
  308 in total

1.  Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype.

Authors:  Hye Sun Kuehn; Julie E Niemela; Karthik Sreedhara; Jennifer L Stoddard; Jennifer Grossman; Christian A Wysocki; M Teresa de la Morena; Mary Garofalo; Jingga Inlora; Michael P Snyder; David B Lewis; Constantine A Stratakis; Thomas A Fleisher; Sergio D Rosenzweig
Journal:  Blood       Date:  2017-08-04       Impact factor: 22.113

2.  Immune receptor signaling: from ubiquitination to NF-κB activation.

Authors:  Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-01-09       Impact factor: 11.530

Review 3.  Caspase work model during pathogen infection.

Authors:  Yan-Bin Ma; Hui-Yun Chang
Journal:  Virol Sin       Date:  2011-12-10       Impact factor: 4.327

Review 4.  Peli: a family of signal-responsive E3 ubiquitin ligases mediating TLR signaling and T-cell tolerance.

Authors:  Wei Jin; Mikyoung Chang; Shao-Cong Sun
Journal:  Cell Mol Immunol       Date:  2012-02-06       Impact factor: 11.530

Review 5.  The amphioxus genome provides unique insight into the evolution of immunity.

Authors:  Larry J Dishaw; Robert N Haire; Gary W Litman
Journal:  Brief Funct Genomics       Date:  2012-03-07       Impact factor: 4.241

Review 6.  NF-κB, the first quarter-century: remarkable progress and outstanding questions.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Genes Dev       Date:  2012-02-01       Impact factor: 11.361

7.  Interdisciplinary collaborative team for blastocyst implantation research: inception and perspectives.

Authors:  Koji Yoshinaga; Mercy PrabhuDas; Christopher Davies; Kenneth White; Kathleen Caron; Thaddeus Golos; Asgerally Fazleabas; Bibhash Paria; Gil Mor; Soumen Paul; Xiaoqin Ye; Sudhansu K Dey; Thomas Spencer; Robert Michael Roberts
Journal:  Am J Reprod Immunol       Date:  2013-11-29       Impact factor: 3.886

Review 8.  Common and Novel Markers for Measuring Inflammation and Oxidative Stress Ex Vivo in Research and Clinical Practice-Which to Use Regarding Disease Outcomes?

Authors:  Alain Menzel; Hanen Samouda; Francois Dohet; Suva Loap; Mohammed S Ellulu; Torsten Bohn
Journal:  Antioxidants (Basel)       Date:  2021-03-09

9.  TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3.

Authors:  Ming-Ming Hu; Qing Yang; Jing Zhang; Shi-Meng Liu; Yu Zhang; Heng Lin; Zhe-Fu Huang; Yan-Yi Wang; Xiao-Dong Zhang; Bo Zhong; Hong-Bing Shu
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

10.  Dual activation of Toll-like receptors 7 and 9 impairs the efficacy of antitumor vaccines in murine models of metastatic breast cancer.

Authors:  Mariela A Moreno Ayala; María Florencia Gottardo; María Soledad Gori; Alejandro Javier Nicola Candia; Carla Caruso; Andrea De Laurentiis; Mercedes Imsen; Slobodanka Klein; Elisa Bal de Kier Joffé; Gabriela Salamone; Maria G Castro; Adriana Seilicovich; Marianela Candolfi
Journal:  J Cancer Res Clin Oncol       Date:  2017-04-21       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.